Home

Stereotaxis, Inc. Common Stock (STXS)

2.4500
+0.2600 (11.87%)
NYSE · Last Trade: Aug 8th, 1:41 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close2.190
Open2.300
Bid2.440
Ask2.450
Day's Range2.290 - 2.490
52 Week Range1.540 - 2.716
Volume652,966
Market Cap210.70M
PE Ratio (TTM)-7.903
EPS (TTM)-0.3
Dividend & YieldN/A (N/A)
1 Month Average Volume635,379

Chart

About Stereotaxis, Inc. Common Stock (STXS)

Stereotaxis Inc is a medical device company that specializes in advanced robotic systems for the cardiovascular catheterization market. The company's innovative technologies focus on enhancing the precision and effectiveness of minimally invasive procedures, particularly in the treatment of arrhythmias and other heart conditions. By integrating advanced robotics and navigation systems, Stereotaxis aims to improve the outcomes of electrophysiological procedures, enabling physicians to perform complex interventions with greater safety and efficiency. Their commitment to innovation and patient care positions them as a leader in the evolving landscape of cardiac treatments. Read More

News & Press Releases

Stereotaxis Inc (NYSEARCA:STXS) Q2 2025 Earnings: Revenue Surpasses Forecasts, Losses Narrower Than Expectedchartmill.com
Stereotaxis Inc (NYSE:STXS) Q2 2025 earnings beat revenue estimates with $8.8M, narrowing losses to -$0.05 EPS. Stock rose 1.83% post-announcement.
Via Chartmill · August 7, 2025
Earnings Scheduled For August 7, 2025benzinga.com
Via Benzinga · August 7, 2025
Earnings Scheduled For May 12, 2025benzinga.com
Via Benzinga · May 12, 2025
What's Going On With Stereotaxis Shares Wednesday?benzinga.com
Stereotaxis shares are moving higher on Wednesday after the company announced it was accepted into the NVIDIA Connect program.
Via Benzinga · March 19, 2025
Earnings Scheduled For March 3, 2025benzinga.com
Via Benzinga · March 3, 2025
Stereotaxis Earnings Previewbenzinga.com
Via Benzinga · November 8, 2024
Recap: Stereotaxis Q4 Earningsbenzinga.com
Via Benzinga · March 4, 2024
Earnings Scheduled For November 11, 2024benzinga.com
Via Benzinga · November 11, 2024
STXS Stock Earnings: Stereotaxis Misses EPS, Misses Revenue for Q2 2024investorplace.com
STXS stock results show that Stereotaxis missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 12, 2024
Hyliion Holdings And 3 Other Penny Stocks Insiders Are Buyingbenzinga.com
Via Benzinga · June 18, 2024
STXS Stock Earnings: Stereotaxis Meets EPS, Misses Revenue for Q1 2024investorplace.com
STXS stock results show that Stereotaxis met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 13, 2024
Earnings Preview For Stereotaxisbenzinga.com
Via Benzinga · March 1, 2024
Recap: Stereotaxis Q3 Earningsbenzinga.com
Via Benzinga · November 9, 2023
3 Penny Stocks That Could Make a Big Comeback by the End of Q2investorplace.com
Although penny stocks to rebound represent one of the riskiest market categories, there could be some substance here.
Via InvestorPlace · April 19, 2024
7 Penny Stocks That Could 5X by the End of 2024investorplace.com
These seven penny stocks to buy have the potential to 5X your money by the end of 2024 if the right catalysts unfold.
Via InvestorPlace · April 10, 2024
Low-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck Withinvestorplace.com
Although lesser-known ideas present high risks, these cheap stocks under $10 could be intriguing for the calculating speculator.
Via InvestorPlace · March 17, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · March 4, 2024
Earnings Scheduled For March 4, 2024benzinga.com
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.
Via Benzinga · March 4, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 12, 2024
Insiders Buying Eyenovia And 3 Other Stocks Under $2benzinga.com
The Dow Jones closed lower by around 80 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · December 6, 2023
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · September 18, 2023
Stereotaxis And 3 Other Stocks Under $2 Insiders Are Aggressively Buyingbenzinga.com
The Dow Jones closed higher by more than 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · August 29, 2023
Stereotaxis Clocks 28% Revenue Growth In Q2 On Continued Demand For Robotic Technologybenzinga.com
Stereotaxis, Inc. (AMEX: STXS) reported Q2 revenues of $7.859 million, 
Via Benzinga · August 10, 2023
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · June 16, 2023
Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Sessionbenzinga.com
Gainers Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781.
Via Benzinga · June 16, 2023